Peoples Bank OH cut its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,208 shares of the healthcare conglomerate’s stock after selling 128 shares during the quarter. Peoples Bank OH’s holdings in UnitedHealth Group were worth $571,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Chesapeake Wealth Management raised its stake in shares of UnitedHealth Group by 7.0% during the 4th quarter. Chesapeake Wealth Management now owns 4,992 shares of the healthcare conglomerate’s stock valued at $2,647,000 after purchasing an additional 326 shares during the period. Westhampton Capital LLC raised its stake in shares of UnitedHealth Group by 1.2% during the 1st quarter. Westhampton Capital LLC now owns 2,587 shares of the healthcare conglomerate’s stock valued at $1,223,000 after purchasing an additional 30 shares during the period. Two Sigma Investments LP bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $87,114,000. Beaumont Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $2,299,000. Finally, Alta Capital Management LLC raised its stake in shares of UnitedHealth Group by 335.1% during the 1st quarter. Alta Capital Management LLC now owns 62,712 shares of the healthcare conglomerate’s stock valued at $29,637,000 after purchasing an additional 48,300 shares during the period. 92.61% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities analysts recently commented on UNH shares. Loop Capital boosted their target price on UnitedHealth Group from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Monday, April 17th. Royal Bank of Canada restated an “outperform” rating and set a $592.00 target price on shares of UnitedHealth Group in a research report on Monday, April 17th. Truist Financial reduced their target price on UnitedHealth Group from $610.00 to $580.00 in a research report on Wednesday, June 14th. Raymond James reiterated a “strong-buy” rating and issued a $630.00 price objective on shares of UnitedHealth Group in a report on Friday, April 14th. Finally, Piper Sandler assumed coverage on UnitedHealth Group in a report on Thursday, May 25th. They issued an “overweight” rating and a $580.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $590.84.
Insider Buying and Selling
UnitedHealth Group Stock Down 1.7 %
Shares of NYSE:UNH opened at $461.58 on Friday. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $558.10. The firm has a market capitalization of $429.74 billion, a P/E ratio of 21.11, a P/E/G ratio of 1.35 and a beta of 0.66. The stock has a 50 day moving average price of $481.95 and a 200-day moving average price of $488.15. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81.
UnitedHealth Group (NYSE:UNH – Free Report) last announced its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The firm had revenue of $91.93 billion during the quarter, compared to analyst estimates of $89.77 billion. During the same quarter in the prior year, the company earned $5.49 EPS. The business’s revenue was up 14.7% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 24.85 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were paid a $1.88 dividend. The ex-dividend date of this dividend was Thursday, June 15th. This represents a $7.52 annualized dividend and a dividend yield of 1.63%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s dividend payout ratio is presently 34.39%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
- Who Wins And Who Loses With China’s Metal Restrictions
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
